Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Short-course radiation matches standard therapy for endometrial cancer

2.

AMA President-Elect Confronts a New Challenge: A Brain Tumor

3.

A study suggests that you should disregard the "pack-years" when determining your eligibility for lung cancer screening.

4.

In a randomized trial, the kinder, gentler regimen for classical Hodgkin wins out.

5.

Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot